Literature DB >> 21921376

Recovery of advanced atrioventricular block by cilostazol.

Asami Nimura1, Nobuyuki Sato, Hitoshi Sakuragi, Satoshi Koyama, Junichi Maruyama, Ahmed Karim Talib, Naoki Nakagawa, Naka Sakamoto, Hisanobu Ota, Yasuko Tanabe, Toshiharu Takeuchi, Yuichiro Kawamura, Naoyuki Hasebe.   

Abstract

We describe a case of advanced atrioventricular (AV) block, in which treatment with cilostazol was effective in recovering the AV conduction. The patient was referred to our hospital for close examination of the advanced AV block and permanent pacemaker implantation. Although the patient had experienced third-degree AV block with occasional AV synchrony for more than two days, the AV conduction completely recovered after treatment with oral cilostazol at 200 mg/day. Here we discuss the possible mechanism of the improvement in the AV conduction by cilostazol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921376     DOI: 10.2169/internalmedicine.50.5228

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Long term effects of cilostazol in a dog with sick sinus syndrome.

Authors:  Nobuyuki Kanno; Tomohiro Suzuki
Journal:  J Vet Med Sci       Date:  2017-05-01       Impact factor: 1.267

2.  Efficacy of cilostazol in canine bradyarrhythmia.

Authors:  Takahiro Ohmori; Yuri Matsumura; Aritada Yoshimura; Shohei Morita; Hiroshi Hasegawa; Daiki Hirao; Ryuji Fukushima
Journal:  Front Vet Sci       Date:  2022-08-16

3.  Effects of cilostazol on the heart rate in healthy dogs.

Authors:  Ryuji Fukushima; Takae Kawaguchi; Shusaku Yamada; Aritada Yoshimura; Daiki Hirao; Takahiro Oomori
Journal:  J Vet Med Sci       Date:  2018-09-25       Impact factor: 1.267

4.  Long-term management of high-grade atrioventricular block using cilostazol in a cat.

Authors:  Naoki Iwasa; Naohito Nishii; Satoshi Takashima; Yui Kobatake; Saki Nomura; Kazuko Iwasa; Tatsuo Iwasa; Tomomi Suzuki; Noboru Machida; Hitoshi Kitagawa
Journal:  JFMS Open Rep       Date:  2019-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.